- Austria / Österreich
- Bosnia and Herzegovina / Босна и Херцеговина
- Bulgaria / България
- Croatia / Hrvatska
- Czech Republic & Slovakia / Česká republika & Slovensko
- Finland / Suomi
- France / France
- Germany / Deutschland
- Greece / ΕΛΛΑΔΑ
- Italy / Italia
- Netherlands / Nederland
- Nordic / Nordic
- Poland / Polska
- Portugal / Portugal
- Romania & Moldova / România & Moldova
- Slovenia / Slovenija
- Serbia & Montenegro / Србија и Црна Гора
- Spain / España
- Switzerland / Schweiz
- Turkey / Türkiye
- UK & Ireland / UK & Ireland
LONDON, UK: The British Orthodontic Society (BOS), a charity and the voice of orthodontists in the UK, has called on manufacturers of orthodontic devices and systems to ensure that all claims are supported by high-quality research. The call is a response to a ruling by the Advertising Standards Authority (ASA) that recent marketing claims made in support of a device designed to speed up treatment are misleading.
OrthoAccel Technologies, based in Germany, stated on its website that its AcceleDent device can speed up treatment by up to 50 per cent and that the device was clinically proven to reduce the pain and discomfort associated with wearing fixed orthodontic appliances by up to 71 per cent. Owing to a complaint in relation to these assertions, the ASA examined research and case studies provided by OrthoAccel Technologies and ruled that the claims could not be substantiated and were misleading.
The ASA ruling states in its adjudication: “The ad must not appear again in its current form. We told OrthoAccel Technologies not to make claims that their AcceleDent device could move teeth faster and reduce pain for brace wearers unless they held adequate evidence to support such claims.”
AcceleDent is a hand-held oscillating device for use by patients wearing fixed orthodontic appliances or aligners. The theory is that the vibrations of the device help the teeth to move faster.
Dr Richard George, Director of External Relations for the BOS, said: “This is the third time in the last few years that the ASA has upheld a claim of misleading advertising in relation to an orthodontic product based on the lack of good quality evidence. Orthodontic treatment can take up to two years to complete and so the quest to speed up the process is understandable.”
“However, what matters most is the quality of the treatment so that the best possible results can be achieved. The priority should be to see an orthodontist or a dentist with recognised enhanced skills who can meet your needs,” he continued.
Neil Hillyard, a patient who completed adult orthodontic treatment and a member of the BOS patient panel, stated: “Patients need confidence that the products marketed to support their orthodontic treatment provide the benefits claimed. This ruling from the ASA provides reassurance that the dental profession continues to challenge misleading advertising, helping patients to avoid unnecessary expense and disappointment.”
Thu. 18 April 2024
4:00 pm UTC (London)
Treatment approaches of advanced periodontal diseases in our daily clinical practice
Mon. 22 April 2024
3:00 pm UTC (London)
Precision in practice: Elevating clinical communication
Tue. 23 April 2024
6:00 pm UTC (London)
Growing your dental practice or DSO with better financial operations
Wed. 24 April 2024
1:00 pm UTC (London)
YITI Lounge: Navigating modern implant dentistry—from prosthetic planning to digital verification, are we there yet?
Wed. 24 April 2024
6:00 pm UTC (London)
Advanced techniques in peri-implant tissue augmentation and maintenance
Thu. 25 April 2024
5:00 pm UTC (London)
Alineadores ClearX: La evolución en el tratamiento ortodóntico con tecnología 4D
Fri. 26 April 2024
5:00 pm UTC (London)
To post a reply please login or register